Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Oct 4;12:8197–8205. doi: 10.2147/OTT.S193031

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Wu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-483-3p-regulated proliferative and invasive capacities of GC cells through targeting CDK6. (A) CDK6 is the target of miR-483-3p. (B) CDK6 was highly expressed in GC tissues than that of paracancerous tissues (P<0.01). (C) CDK6 expression in GC cell lines (P<0.01). (E) Pearson correlation analysis showed a negative correlation between expressions of miR-483-3p and CDK6 (R=−0.635, p=0.0009). (E) Dual-luciferase reporter gene assay showed the binding between CDK6 and miR-483-3p. (F and G) The mRNA and protein levels of CDK6 in SGC-7901 (F) and BGC-823 (G) cells transfected with miR-483-3p mimics. **P<0.01; ***P<0.001.